文献速递神经肿瘤

匹兹堡化合物B(PiB)PET显像用于脑膜瘤及其他颅内肿瘤的鉴别

Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors.
PubMed 文献 · J Neurooncol · 2017-11-08

回顾2006至2015年2472例接受PiB PET/CT检查的患者,其中45例(1.8%)有 probable 或 definite 颅内肿瘤。脑膜瘤患者病灶SUVmax均值为2.05(标准差1.37),非脑膜瘤肿瘤患者为1.00(标准差0.42),p<0.01。病灶与小脑SUVmax比值曲线下面积为0.91,以1.68为界值时,诊断脑膜瘤的特异度为100%(95%CI 79-100%),敏感度为76%(95%CI 57-90%)。

要点

  • PiB PET/CT中颅内肿瘤的PiB摄取是脑膜瘤高度特异且敏感度尚可的标志物。
  • 脑膜瘤病灶SUVmax均值2.05(标准差1.37),非脑膜瘤肿瘤为1.00(标准差0.42),p<0.01。
  • 病灶与小脑SUVmax比值≥1.68时,诊断脑膜瘤特异度100%(95%CI 79-100%),敏感度76%(95%CI 57-90%)。

核心结论

  • 颅内肿瘤内的PiB PET摄取是脑膜瘤高度特异且敏感度尚可的标志物。

研究设计与样本

  • 回顾性分析2006至2015年接受PiB PET/CT检查的2472例患者,识别出45例(1.8%)有 probable 或 definite 颅内肿瘤。
  • 肿瘤类型根据MR表现或病理(如可获得)分类,比较各肿瘤类型的肿瘤PiB活性SUVmax。

主要发现

  • 肿瘤类型为脑膜瘤29/45(64%)、前庭神经鞘瘤7/45(16%)、垂体大腺瘤4/45(9%)、转移性疾病2/45(4%)、其他3/45(7%)。
  • 脑膜瘤患者病灶SUVmax均值为2.05(标准差1.37),非脑膜瘤肿瘤患者为1.00(标准差0.42),p<0.01。
  • 病灶与小脑SUVmax比值的受试者工作特征曲线下面积为0.91,界值为1.68。
  • 以1.68为界值及以上,诊断脑膜瘤的特异度为100%(95%CI 79-100%),敏感度为76%(95%CI 57-90%)。

关键数值与推荐

  • 病灶与小脑SUVmax比值≥1.68时,诊断脑膜瘤特异度100%(95%CI 79-100%),敏感度76%(95%CI 57-90%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步的前瞻性评估来验证该结果,并评估市售β-淀粉样蛋白放射性示踪剂在脑膜瘤识别中的性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Meningiomas are the most common intracranial tumors. Diagnosis by MRI is generally straightforward, but lack of imaging specificity can present a diagnostic dilemma, particularly in patients with cancer. We report our experience with meningioma identification on Pittsburgh compound B (PiB) PET/CT. Patients who underwent PiB PET/CT from 2006 to 2015 were reviewed to identify those with intracranial tumors. Tumor types were classified by MR appearance, or by pathology when available. Maximum standardized uptake value (SUVmax) measurements of tumor PiB activity were compared across tumor types. 2472 patients underwent PiB PET/CT in the period of interest; 45 patients (1.8%) had probable or definite intracranial tumor. Tumor types were meningioma (29/45, 64%), vestibular schwannoma (7/45, 16%), pituitary macroadenoma (4/45, 9%), metastatic disease (2/45, 4%), and others (3/45, 7%). In patients with meningioma, the mean lesion SUVmax was 2.05 (SD 1.37), versus 1.00 (SD 0.42) in patients with non-meningioma tumors (p < 0.01). A receiver operating curve was created for lesion:cerebellum SUVmax ratio, with an area under the curve of 0.91 for a value of 1.68. At or above this ratio, specificity for meningioma was 100% (95% CI 79-100%) and sensitivity was 76% (95% CI 57-90%). PiB PET activity within an intracranial tumor is a highly specific and reasonably sensitive marker of meningioma. Further prospective evaluation is warranted to validate this result as well as to assess the performance of commercially available beta-amyloid radiotracers in meningioma identification.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Johnson DR, Hunt CH, Nathan MA, et al. Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors. J Neurooncol. 2017. PMID: 29116483. doi:10.1007/s11060-017-2661-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。